INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Ginkgo Bioworks Holdings, Inc. (DNA) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Ginkgo Bioworks Holdings, Inc. (“Ginkgo” or the “Company”) (NYSE: DNA) investors concerning the Company’s possible violations of federal securities laws.

On October 6, 2021, Scorpion Capital published a 175-page research report alleging that Ginkgo Bioworks is a "colossal scam" and that its business model is a "shell game." According to the report, Ginkgo Bioworks is highly dependent on related party transaction revenues and the Company is a "Frankenstein mash-up of the worst frauds of the last 20 years."

On this news, the Company’s share price fell as much as 17% during intraday trading on October 6, 2021, thereby injuring investors.

If you purchased Ginkgo securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at [phone], toll-free at [phone], or by email to [e-mail], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.